SequelSEC

ESTABLISHMENT LABS HOLDINGS INC. ESTA

Orthopedic, Prosthetic & Surgical Appliances & Supplies · CIK 0001688757 · Fiscal year ends 1231

Revenue
$211.08M
Fiscal year ended 2025-12-31
Operating income
-$39.01M
Fiscal year ended 2025-12-31
Free cash flow
-$56.94M
Fiscal year ended 2025-12-31

Valuation, from the filing

Public float$975.10MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$33.26Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue4.6×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity41.4×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Orthopedic, Prosthetic & Surgical Appliances & Supplies filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Long-term debt / equity10.51x100th
Revenue YoY growth27.1%100th
Gross margin69.3%76th
SBC / revenue5.4%68th
Current ratio3.04x57th
CapEx / revenue2.9%55th
FCF margin-27.0%45th
Net margin-24.2%52th
Operating margin-18.5%48th
R&D / revenue9.6%50th

ESTABLISHMENT LABS HOLDINGS INC. (ESTA) reported revenue of $211.08M and net income of -$51.06M for the fiscal year ended 2025-12-31. This page shows 9 annual periods of income statement, balance sheet and cash flow figures normalized from ESTABLISHMENT LABS HOLDINGS INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies.

Income

ESTABLISHMENT LABS HOLDINGS INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue$211.08M$166.02M$165.15M$161.70M$126.68M$84.68M$89.56M$61.21M$34.68M
Cost of revenue$64.77M$56.50M$58.17M$55.10M$41.28M$32.17M$34.70M$25.09M$16.98M
Gross profit$146.31M$109.52M$106.98M$106.60M$85.40M$52.50M$54.86M$36.12M$17.70M
Operating income-$39.01M-$49.99M-$65.03M-$39.66M-$25.14M-$27.92M-$30.94M-$23.86M-$19.98M
Net income-$51.06M-$84.60M-$78.50M-$75.21M-$41.14M-$38.12M-$38.15M-$21.10M-$34.90M
Research & development$20.25M$19.71M$26.43M$20.27M$18.32M$13.79M$14.99M$12.69M$6.86M
Weighted-average diluted sharesshares 29.62Mshares 28.16Mshares 25.60Mshares 24.46Mshares 23.97Mshares 23.32Mshares 20.54MUnavailableUnavailable
Pretax income-$58.02M-$84.63M-$78.58M-$72.82M-$39.71M-$38.02M-$37.51M-$20.88M-$34.79M
Income tax expense-$6.96M-$32.00K-$81.00K$2.38M$1.43M$104.00K$640.00K$215.00K$105.00K
Diluted EPS$-1.72$-3.00$-3.07$-3.08$-1.72$-1.63$-1.86UnavailableUnavailable
Selling, general & administrative$165.07M$139.81M$145.58M$125.98M$92.23M$66.62M$70.81M$47.30M$30.82M
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

ESTABLISHMENT LABS HOLDINGS INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Cash & equivalents$75.57M$90.35M$40.04M$66.36MUnavailableUnavailableUnavailable$52.64M$10.86M
Total assets$357.17M$346.83M$268.64M$211.06M$139.53M$156.39M$116.53M$116.57M$57.10M
Current assets$249.94M$243.04M$174.90M$149.90M$113.27M$132.30M$95.84M$99.44M$39.38M
Total liabilities$333.62M$293.74M$250.25M$219.25M$88.79M$81.43M$76.92M$47.09M$62.11M
Current liabilities$82.14M$68.28M$57.15M$38.96M$31.89M$25.90M$23.24M$16.45M$57.44M
Total equity incl. NCI$23.55M$53.10M$18.40M-$8.18M$50.74M$74.96M$39.61M$69.48M-$5.01M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$85.61M$78.77M$79.47M$36.58M$28.41M$23.21M$28.66M$24.84M$13.17M
Accounts receivable$77.50M$65.00M$46.92M$35.42M$24.44M$19.13M$22.77M$17.65M$13.11M
Goodwill$1.21M$1.21M$465.00K$465.00K$465.00K$465.00K$465.00K$465.00K$465.00K
Long-term debt$247.52M$219.58M$188.74M$175.46M$51.91M$49.83M$48.14MUnavailableUnavailable
Accounts payable$43.11M$44.76M$41.62M$20.03M$14.48M$9.72M$10.37M$6.24M$9.13M

Cash flow

ESTABLISHMENT LABS HOLDINGS INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Operating cash flow-$50.89M-$58.52M-$88.51M-$52.17M-$27.53M-$12.51M-$29.98M-$33.88M-$31.97M
Capital expenditures$6.05M$6.11M$7.91M$2.85M$2.42M$2.11M$6.29M$1.73M$901.00K
Investing cash flow-$7.03M-$15.61M-$24.55M-$34.79M-$7.16M-$5.56M-$7.77M-$5.73M-$845.00K
Financing cash flow$40.43M$125.90M$86.23M$100.26M$4.05M$64.67M$22.79M$81.53M$42.99M
Net change in cash-$14.78M$50.31M-$26.32M$12.94M-$31.11M$46.87M-$14.98M$41.78M$10.38M
Stock-based compensation$11.42M$14.40M$14.36M$13.36M$10.41MUnavailableUnavailableUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$0$4.51M
Depreciation & amortization$6.20M$4.70M$2.80M$2.50M$2.50MUnavailableUnavailableUnavailableUnavailable

Derived

ESTABLISHMENT LABS HOLDINGS INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Free cash flow-$56.94M-$64.63M-$96.42M-$55.02M-$29.96M-$14.62M-$36.27M-$35.62M-$32.87M
Gross margin69.3%66.0%64.8%65.9%67.4%62.0%61.3%59.0%51.0%
Operating margin-18.5%-30.1%-39.4%-24.5%-19.8%-33.0%-34.5%-39.0%-57.6%
FCF margin-27.0%-38.9%-58.4%-34.0%-23.6%-17.3%-40.5%-58.2%-94.8%
SBC / revenue5.4%8.7%8.7%8.3%8.2%UnavailableUnavailableUnavailableUnavailable
Current ratio3.04x3.56x3.06x3.85x3.55x5.11x4.12x6.05x0.69x
Revenue YoY growth27.1%0.5%2.1%27.6%49.6%-5.5%46.3%76.5%Unavailable
Net margin-24.2%-51.0%-47.5%-46.5%-32.5%-45.0%-42.6%-34.5%-100.6%
R&D / revenue9.6%11.9%16.0%12.5%14.5%16.3%16.7%20.7%19.8%
CapEx / revenue2.9%3.7%4.8%1.8%1.9%2.5%7.0%2.8%2.6%
Long-term debt / equity10.51xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ESTA in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-07View SEC filing
10-Q · Filed 2026-05-08View SEC filing
10-K · Filed 2026-02-27View SEC filing
10-Q · Filed 2025-11-07View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-09View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.